Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Kalydeco (ivacaftor). Show all posts
Showing posts with label Kalydeco (ivacaftor). Show all posts
Wednesday, June 12, 2019

FDA Approves Kalydeco (ivacaftor) as First and Only CFTR Modulator to Treat Eligible Infants with CF as Early as Six Months of Age

›
In continuation of my update on Kalydeco (ivacaftor)  Vertex Pharmaceuticals Incorporated  announced the U.S. Food and Drug Administra...
Wednesday, October 10, 2018

FDA Approves Kalydeco (ivacaftor) for Cystic Fibrosis in Children Ages 12..

›
 Vertex Pharmaceuticals Incorporated  announced the U.S. Food and Drug Administration (FDA) approved  Kalydeco  ( ivacaftor ) to i...
Sunday, February 19, 2012

FDA Approves Kalydeco to Treat Rare Form of Cystic Fibrosis

›
The U.S. FDA approved  Kalydeco  (ivacaftor) for the treatment of a rare form of cystic fibrosis (CF) in patients ages 6 years and older who...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.